Business
InMode Expects Record Third Quarter Results, Revenues Between $59.2-$59.5M, Non-GAAP Earnings per Diluted Share Between $0.60-$0.62; Increasing Full Year 2020 Revenue Guidance to $192-$195M
- Conference call to be held on November 12 at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading
About this update from Inmode Ltd.
[{"type":"text","content":"- Conference call to be held on November 12 at 8:30 a.m. Eastern Time\n\n\n\n \n \n YOKNEAM, Israel, Oct. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it will release its financial results for the third quarter 2020 before the Nasdaq market opens on Thursday, November 12, 2020. \nInMode is currently finalizing its financial results for the three months ended September 30, 2020. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of InMode's financial results for such period, subject to final adjustments and other developments that may arise between now and the time such financial results are finalized. Based on preliminary results, management expects:\n Record revenues for the third quarter of 2020 in the range of $59.2 million to $59.5 million. Non-GAAP[1] earnings per diluted share for the third quarter of 2020 in the range of $0.60 to $0.62. Revenue for the full year of 2020 in the range of $192 million to $195 million. Non-GAAP gross margin for the full year of 2020 in the range of 84% to 86%.[1] Please refer to \"Use of Non-GAAP Financial Measure\" below for important information about non-GAAP financial measures. Non-GAAP financial results exclude stock-based compensation and related tax adjustments.\n\"InMode has proven once again that its two main electro-surgical proprietary and unique technologies; minimally invasive and hands-free, are becoming the gold standard of the minimally invasive surgical procedures for a variety of medical indications,\" commented Moshe Mizrahy, InMode's CEO. \"We expect the underlying interest in our differentiated product suite will continue to drive sales into the fourth quarter of 2020. As a result, we decided to increase our full year 2020 revenue guidance to $192-$195 million.\" \nMembers of InMode's management team will host a conference call to discuss the third quarter 2020 financial results on November 12, 2020, at 8:30 a.m. Eastern Time. The presenters include Mr. Moshe Mizrahy, Chairman and Chief Executive Officer; Dr. Michael Kreindel, co-founder and Chief Technology Officer; Mr. Yair Malca, Chief Financial Officer; Mr. Shakil Lakhani, President of North America; and Dr. Spero Theodorou, Chief Medical Officer.\nThe C...